Last Renal Webinars before Xmas 2020

ISN Webinar: New perspectives in the management of CKD in T2D: the emerging role of MRAs Wed, Dec 16, 2020 21:00 - 23:00 MUT (17:00-18:00 UTC) Register link. Despite the recent advances in the management CKD in T2D, there are residual risk that needs to be tackled by new therapies. In this webinar, we will… Continue reading Last Renal Webinars before Xmas 2020

Top 10 Takeaways from the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD

Released to coincide with World Diabetes Day earlier this month, the KDIGO have released a comprehensive set of guidelines that can be accessed on their website. For those too busy to read the full document, KDIGO has an illustrated summary reproduced below. What is the KDIGO? Global Science. Local Change. KDIGO is the global nonprofit organization developing… Continue reading Top 10 Takeaways from the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD

Renal Webinars 5- 12th November 2020

ISN-KDIGO Webinar: Chronic Kidney Disease Early Identification & Intervention November 5 at 20.00 MUT (16.00 UTC) Register here Chronic kidney disease causes substantial global morbidity and increases cardiovascular and all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems and governments should prioritize early identification… Continue reading Renal Webinars 5- 12th November 2020

Weekend Webinars: Sickle Cell and Insulin

Sickle Cell in Focus Northeast Chapter of Indian Society of Hematology And Transfusion Medicine Guwahati, Assam & Novartis invites you for the Live Webinar on "Sickle Cell in Focus".  This Meeting will be held on Friday 16th October 2020, 05.30 - 07.30pm Invited Guest International SpeakerDr. Erfan NurClinical Hematologist,SCT Program Director,University of Medical Centers, Amsterdam, Netherlands… Continue reading Weekend Webinars: Sickle Cell and Insulin

Webinars for week ending 4 October

Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease 29th Sep 2020 at 20:00 – 21:00 MUT Registration link. Leading experts in the care of individuals with diabetic kidney disease (DKD) will describe what is the new standard of care for DKD, discuss the clinical indications for SGLT2 inhibitors, and consider payment issues associated with… Continue reading Webinars for week ending 4 October

Ground breaking results from key trial : DAPA CKD

The much awaited outcome of the DAPA-CKD (Dapagliflozin And Prevention of Adverse Outcomes in Chronic Kidney Disease ) trial was presented on 30 August 2020 at the ESC (European Society of Cardiology) Congress 2020 by Prof H. Heerspink. Dapagliflozin is an SGLT2 ( Sodium-Glucose Co-transporter 2) inhibitor being used,so far, in the treatment of type… Continue reading Ground breaking results from key trial : DAPA CKD

1st of 3 Live Webinars on Diabetic Kidney Disease

Management of Diabetes and Kidney Disease through COVID19 Join ASN and the DKD-C Task Force Tuesday, August 18, from 20:00–21:30 Mauritius Time Link: Detail the care needs and the patient experience managing diabetes and kidney disease during the COVID-19 pandemic. Topics for presentation and discussion: Welcome and Opening StatementPopulation Susceptibility To DiabetesDiabetes and Kidney… Continue reading 1st of 3 Live Webinars on Diabetic Kidney Disease

Giving Credence to the Bigger SGLT2i Story

In this talk, given on 29 July 2020 in Port Louis, Dr Davy Ip of the Renal Association presents his thoughts about diabetes, the kidney and the SGLT2 inhibitors through global and local perspectives. He looks back to where we came from, assesses how we are (not) doing now and wonders if there'll be a… Continue reading Giving Credence to the Bigger SGLT2i Story